Guru Ownership Trend
Guru Analysis for Ligand Pharmaceuticals Incorporated (LGND)
Ligand Pharmaceuticals Incorporated (LGND), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $74.49 M.
Top institutional holders include Private Capital and Ken Fisher.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $19.33 M net outflow during the quarter.
Recent activity highlights Ray Dalio who increased their stake by 226.6%. Conversely, Private Capital reduced exposure by 8.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Ligand Pharmaceuticals Incorporated (LGND)
Major holders include Private Capital ($39.5 M), Ken Fisher ($24.74 M), Joel Greenblatt ($1.77 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 358,460 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $19.33 M, with 3 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 2 fully exited LGND. The total reported sell value was $24.14 M.
Yes, 0 managers opened new positions in LGND, and 3 increased their existing holdings. The total reported buy value was $4.81 M.